Our Respiratory Pathogen Detection Panel (RPP) covers more than 40 pathogens which includes SARS-CoV-2 causing COVID-19. Respiratory tract infections may cause various diseases of the upper and lower respiratory tracts.

Traditional diagnostic tests such as immunoassays and culture based methods have technical limitations to detect pathogens and have became a major concern in clinical settings. Molecular testing provide a robust, fast and more sensitive method of detection pathogens. Moreover, our RPP test allows to not only rule out COVID-19 but also evaluate which pathogen is causing the respiratory disease in patients and thus guide therapeutic approach.

PMCDx, Inc. offers an accurate diagnostics test for only COVID-19 condition upon healthcare providers or patients request.